Cost benefit of pharmacist concurrent monitoring of cefazolin prescribing.
D001424:Bacterial Infections / Q000188:drug therapy / Q000517:prevention & control; D002437:Cefazolin / Q000008:administration & dosage; D003362:Cost-Benefit Analysis; D004363:Drug Utilization / Q000191:economics*; D006801:Humans; D007275:Injections, Intravenous; D010607:Pharmacy Service, Hospital; D014861:Washington
D002437:Cefazolin